0.0050
0.0000
(0.00%)
At close: January 24 at 11:17:06 AM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
413.1650
254.8960
1,379.7720
2,714.6980
2,592.6130
Cost of Revenue
192.3350
111.2340
103.5590
42.7790
--
Gross Profit
220.8300
143.6620
1,276.2130
2,671.9190
2,592.6130
Operating Expense
2,706.4230
2,963.9480
3,774.2490
4,039.3730
3,118.7170
Operating Income
-2,485.5930
-2,820.2860
-2,498.0360
-1,367.4540
-526.1040
Net Non Operating Interest Income Expense
-223.6720
-141.0470
-189.3000
-441.6560
-515.0590
Other Income Expense
33.5430
-3.3890
-522.7080
-0.4820
-4.1970
Pretax Income
-2,675.7220
-2,964.7220
-3,210.0440
-1,809.5920
-1,045.3600
Net Income Common Stockholders
-2,675.7220
-2,964.7220
-3,210.0440
-1,809.5920
-1,045.3600
Diluted NI Available to Com Stockholders
-2,675.7220
-2,964.7220
-3,210.0440
-1,809.5920
-1,045.3600
Basic EPS
-0.01
-0.02
-0.02
-0.01
-0.01
Diluted EPS
-0.01
-0.02
-0.02
-0.01
-0.01
Basic Average Shares
132,634.4310
132,634.4310
132,634.4310
128,849.8590
93,180.7090
Diluted Average Shares
132,634.4310
132,634.4310
132,634.4310
128,849.8590
93,180.7090
Total Expenses
2,898.7580
3,075.1820
3,877.8080
4,082.1520
3,118.7170
Net Income from Continuing & Discontinued Operation
-2,675.7220
-2,964.7220
-3,210.0440
-1,809.5920
-1,045.3600
Normalized Income
-2,666.2040
-2,961.3330
-2,687.3360
-1,809.1100
-1,041.1630
Interest Income
5.3450
4.1350
24.7080
13.1840
4.5340
Interest Expense
229.0170
145.1820
214.0080
454.8400
519.5930
Net Interest Income
-223.6720
-141.0470
-189.3000
-441.6560
-515.0590
EBIT
-2,446.7050
-2,819.5400
-2,996.0360
-1,354.7520
-525.7670
EBITDA
-2,313.5380
-2,681.3770
-2,866.2050
-1,226.6430
-314.8010
Reconciled Cost of Revenue
192.3350
111.2340
103.5590
42.7790
--
Reconciled Depreciation
133.1670
138.1630
129.8310
128.1090
210.9660
Net Income from Continuing Operation Net Minority Interest
-2,675.7220
-2,964.7220
-3,210.0440
-1,809.5920
-1,045.3600
Total Unusual Items Excluding Goodwill
-9.5180
-3.3890
-522.7080
-0.4820
-4.1970
Total Unusual Items
-9.5180
-3.3890
-522.7080
-0.4820
-4.1970
Normalized EBITDA
-2,304.0200
-2,677.9880
-2,343.4970
-1,226.1610
-310.6040
12/31/2020 - 3/18/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CHOOF Choom Holdings Inc.
0.0000
0.00%
TLLTF TILT Holdings Inc.
0.0080
+12.68%
CRON.TO Cronos Group Inc.
2.7300
-0.73%
LFST.V Lifeist Wellness Inc.
0.0450
0.00%
RVV.CN Revive Therapeutics Ltd.
0.0100
0.00%
OPTN OptiNose, Inc.
6.55
-2.96%
BCBC.CN The BC Bud Corporation
0.1400
0.00%
PTPI Petros Pharmaceuticals, Inc.
0.3280
-4.93%
SBBC.V Simply Better Brands Corp.
1.1600
-2.52%
MDP.TO Medexus Pharmaceuticals Inc.
4.9200
+10.07%